Can Glycosylation Serve as a Biomarker for Cancer?
Yes, altered glycosylation patterns have the potential to serve as biomarkers for cancer diagnosis and prognosis. For instance, specific glycan structures can be detected in the blood or tissues of cancer patients, providing valuable information about the presence and progression of the disease.
